Literature DB >> 21823537

Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity.

Rafael M Mantovani1, Danyelle R A Rios, Letícia C R Moura, Juliana M Oliveira, Flávia F Carvalho, Sarah B Cunha, Maria de Fátima S Viana, Joel A Lamounier, Juni C Castro, Luci Maria S Dusse, Ana Cristina Simões e Silva.   

Abstract

BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) has been considered as a cardiovascular risk factor, mainly because of its strong association with insulin resistance.
METHODS: To detect independent predictors of circulating PAI-1 levels in obese pediatric patients, we evaluated 86 subjects (mean age 10.7 +/- 2.8 years), 42 of whom were male (49%). Subjects were divided in two groups according to body mass index (BMI): obese subjects (n=61) and healthy non-obese controls (n=25). They were also divided by pubertal status. Besides anthropometric data, levels of PAI-1, leptin and biochemical markers of metabolic syndrome were measured.
RESULTS: The obese group had higher levels of PAI-1, leptin and biochemical markers of metabolic syndrome than nonobese controls (p<0.05). However, multivariate regression analysis showed that only puberty progression (p=0.005) and abdominal circumference/height index (p=0.002) remained independent predictors of PAI-1 levels.
CONCLUSION: In pediatric obesity, fat mass accumulation, mainly of visceral fat, and puberty progression were related to high PAI-1 levels, which might in turn contribute to cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21823537     DOI: 10.1515/jpem.2011.015

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  5 in total

1.  Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial.

Authors:  Ruth S Weinstock; Kimberly L Drews; Sonia Caprio; Natasha I Leibel; Siripoom Vudhipoom McKay; Philip S Zeitler
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

Review 2.  Adipokines: a link between obesity and dementia?

Authors:  Amanda J Kiliaan; Ilse A C Arnoldussen; Deborah R Gustafson
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 3.  Obesity and dementia: adipokines interact with the brain.

Authors:  Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Eur Neuropsychopharmacol       Date:  2014-03-20       Impact factor: 4.600

4.  [Frequency of overweight and obesity in children and adolescents with autism and attention deficit/hyperactivity disorder].

Authors:  Arthur Kummer; Izabela Guimarães Barbosa; David Henrique Rodrigues; Natália Pessoa Rocha; Marianna da Silva Rafael; Larissa Pfeilsticker; Ana Cristina Simões E Silva; Antônio Lúcio Teixeira
Journal:  Rev Paul Pediatr       Date:  2015-10-09

5.  Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.

Authors:  Sándor Somodi; Ildikó Seres; Hajnalka Lőrincz; Mariann Harangi; Péter Fülöp; György Paragh
Journal:  Int J Endocrinol       Date:  2018-05-30       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.